Rafael Ríos-Tamayo

25PUBLICATIONS
117CO-AUTHORS
Medical mycologyPhysiotherapyAutoimmunityInnate immunityGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jul 24, 2026
MRD dynamics predicts progression and reveals a vulnerable state for immunotherapy interception in multiple myeloma.

|Jun 26, 2026
The Current Role of Physiotherapy in Systemic Light-Chain (AL) Amyloidosis and Multiple Myeloma.

|Feb 27, 2026
The Evolving Landscape of Anti-Clonal Therapy in Newly Diagnosed Systemic Light-Chain (AL) Amyloidosis: Evidence- and Time-Based Comparison with Multiple Myeloma.

Rafael Ríos-Tamayo

|Jan 29, 2026
Immune biomarkers of increased infection risk in multiple myeloma.

Aintzane Zabaleta, Luis-Esteban Tamariz-Amador, Ioannis V Kostopoulos

|Jun 11, 2025
High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial.

Juan José Lahuerta, Jesús San-Miguel, Ana Jiménez-Ubieto

|Apr 15, 2025
Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma.

Camila Guerrero, Maria-Jose Larrayoz, Irache Erdozain

Pageof 5

Frequent Collaborators

18 joint publications

Juan-José Lahuerta

15 joint publications

Joaquín Martínez-López

15 joint publications

Juan José Lahuerta

15 joint publications

Jesus San-Miguel